- Home
- RKDA vs RNAZ Comparison
RKDA vs RNAZ Comparison
Compare RKDA & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKDA
- RNAZ
- Stock Information
- Founded
- RKDA 2002
- RNAZ 2016
- Country
- RKDA United States
- RNAZ United States
- Employees
- RKDA N/A
- RNAZ N/A
- Industry
- RKDA Agricultural Chemicals
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- RKDA Industrials
- RNAZ Health Care
- Exchange
- RKDA Nasdaq
- RNAZ Nasdaq
- Market Cap
- RKDA 6.6M
- RNAZ 7.2M
- IPO Year
- RKDA 2015
- RNAZ 2021
- Fundamental
- Price
- RKDA $3.98
- RNAZ $8.08
- Analyst Decision
- RKDA Strong Buy
- RNAZ Strong Buy
- Analyst Count
- RKDA 1
- RNAZ 1
- Target Price
- RKDA $6.00
- RNAZ $20.00
- AVG Volume (30 Days)
- RKDA 6.2K
- RNAZ 4.3M
- Earning Date
- RKDA 03-27-2025
- RNAZ 03-31-2025
- Dividend Yield
- RKDA N/A
- RNAZ N/A
- EPS Growth
- RKDA N/A
- RNAZ N/A
- EPS
- RKDA N/A
- RNAZ N/A
- Revenue
- RKDA $5,482,000.00
- RNAZ N/A
- Revenue This Year
- RKDA N/A
- RNAZ N/A
- Revenue Next Year
- RKDA $30.00
- RNAZ N/A
- P/E Ratio
- RKDA N/A
- RNAZ N/A
- Revenue Growth
- RKDA 24.00
- RNAZ N/A
- 52 Week Low
- RKDA $1.85
- RNAZ $2.66
- 52 Week High
- RKDA $10.31
- RNAZ $66.33
- Technical
- Relative Strength Index (RSI)
- RKDA 25.98
- RNAZ 48.31
- Support Level
- RKDA $4.74
- RNAZ $10.02
- Resistance Level
- RKDA $4.85
- RNAZ $11.30
- Average True Range (ATR)
- RKDA 0.20
- RNAZ 1.97
- MACD
- RKDA -0.07
- RNAZ -0.18
- Stochastic Oscillator
- RKDA 13.61
- RNAZ 26.75
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.